ATXI Description — Avenue Therapeutics Inc
Avenue Therapeutics is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. Co.'s product candidates include AJ201 for the treatment of spinal and bulbar muscular atrophy, intravenous Tramadol for the treatment of post-operative acute pain, and BAER-101 for the treatment of epilepsy and panic disorders.
|
|
Free ATXI Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Strong Buy (4.00 out of 4) 98th percentile
(ranked higher than approx. 98% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |